Peptide therapy is a medical treatment that utilizes specific sequences of amino acids (peptides) to signal biological pathways in the body. These signaling molecules act as precise messengers, binding to cell receptors to modulate physiological functions such as tissue repair, immune response, and metabolic regulation with high specificity and minimal side effects.

The FDA regulatory status of peptides varies. Many peptides, such as insulin and GLP-1 agonists (e.g., Semaglutide), are fully FDA-approved for specific medical indications. Others are currently classified as investigational new drugs (INDs) or are used in clinical research settings. Providers must stay updated on the latest FDA guidance and compounding pharmacy standards.

Providers can integrate peptide therapy by completing evidence-based, CME-accredited training that covers biochemistry, clinical protocols, safety standards, and regulatory compliance. Integration requires a deep understanding of patient selection, dosing calculations, and monitoring protocols to ensure safe and effective outcomes.

While both are signaling molecules, peptides are shorter chains of amino acids (typically <50) that often act as precursors or modulators of biological activity. Hormones can be peptides, steroids, or amino acid derivatives and typically have broader, systemic effects. Peptide therapy is often more targeted, focusing on specific cellular signaling pathways.

Our "Peptide Therapy in Clinical Practice" course is designed for licensed healthcare professionals, including MDs, DOs, NPs, PAs, and RNs. The curriculum is tailored to the needs of providers looking to master the science of signaling and implement regenerative protocols in a clinical setting.

Yes, Advera Care provides CME-accredited education. Our curriculum is designed to meet the rigorous standards of continuing medical education, ensuring that providers receive high-quality, evidence-based training that translates directly to clinical excellence.